| Mr Steve Francis Mikita, SLP | |
|
1626 Davis Rd, West Palm Beach, FL 33406-5640 | |
| (561) 439-8897 | |
| Not Available |
| Full Name | Mr Steve Francis Mikita |
|---|---|
| Gender | Male |
| Speciality | Speech-language Pathologist |
| Location | 1626 Davis Rd, West Palm Beach, Florida |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053650192 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | SA2565 (Florida) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mr Steve Francis Mikita, SLP 9690 Pine Trail Ct, Lake Worth, FL 33467-2366 Ph: (561) 969-2983 | Mr Steve Francis Mikita, SLP 1626 Davis Rd, West Palm Beach, FL 33406-5640 Ph: (561) 439-8897 |
News Archive
The proportion of health care personnel reporting that they always or often queried their patients regarding alcohol use has increased significantly. This is particularly notable with nurses, where the proportion has doubled to 60 per cent, and midwives, where 92 per cent estimate their capacity to identify risk consumption as good or very good.
It has become increasingly clear that patients in the United States are starting dialysis at higher and higher levels of kidney function. A team of researchers, led by Dr. Ann O'Hare, University of Washington associate professor of medicine and affiliate investigator at Group Health Research Institute, set out recently to find out what this means for patients, and how much earlier patients are starting dialysis compared with past practices.
Keryx Biopharmaceuticals, Inc. today announced that data from its Phase 1/2 clinical trial of KRX-0401 (perifosine) in combination with bortezomib (+/- dexamethasone) has been selected for poster presentation at the upcoming 51st Annual Meeting of the American Society of Hematology (ASH), to be held in New Orleans from December 5-8, 2009.
Presidio Pharmaceuticals, Inc. today announced progress with its HCV antiviral drug discovery and development programs. A primary company objective is to advance multiple potent and safe inhibitors that target multiple HCV proteins and provide pan-genotypic coverage, as we believe such combination therapies will more adequately address the global medical need in the future.
Although this therapy is not curative, it nevertheless reduced the autistic disorders' severity in three-quarters of the children. The researchers have filed a request for authorisation to perform a multi-centre European clinical trial in order to determine more precisely the population concerned by this therapy.
› Verified 1 days ago
Hannah Mallen, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5589 Okeechobee Blvd, West Palm Beach, FL 33417 Phone: 224-303-1400 | |
Mrs. Melynda Kay Lamotte, M.S. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 440 32nd St, West Palm Beach, FL 33407 Phone: 561-889-4622 | |
Danielle Laskey Wallace, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2401 Country Oaks Ln, West Palm Beach, FL 33410 Phone: 561-862-7793 | |
Alyssa Savery, M.S. CCC SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6414 13th Rd S, Suite 200, West Palm Beach, FL 33415 Phone: 561-478-9900 | |
Samantha Kirby, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5205 Village Blvd, West Palm Beach, FL 33407 Phone: 561-436-8458 | |
Bilingual Therapies For Children And Adults, Inc. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2393 S Congress Ave, Suite 200, West Palm Beach, FL 33406 Phone: 561-253-0422 Fax: 561-649-0210 |